Arpa-H sbir phase II topic 4 for intra-operative contrast agents
Ended Definitive Contract Awarded Last action
- Contract number
- 75N91023C00053
- Awardee
-
Optosurgical, LLC UEI N5FFBMLQHAJ9
- Awarding agency
-
National Institutes of Health
Department of Health and Human Services
- Obligated
- $3,500,000
Award facts
- Opportunity
-
- A Solicitation of the Advanced Research Projects Agency for Health (ARPA-H) for Small Business Innovation Research (SBIR) Contract Proposals Pre-Solicitation · 75N91023R00041 · Posted May 17, 2023
- Contract value 100% obligated
- $3,500,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- Total Small Business
- Competition
- Full and Open Competition after exclusion of sources · 2 offers Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Columbia, MD 21046, USA
- Research
- SBIR Program Phase II Action
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Close Out | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Other Administrative Action | $0 | |
| Transfer Action | $0 | |
| Other Administrative Action | $0 | |
| Original award | $3,500,000 |
About this award
Optosurgical, LLC, a small business specializing in advanced surgical imaging and visualization technologies, was awarded a $3.5 million Phase II Small Business Innovation Research (SBIR) contract by the National Institutes of Health's Advanced Research Projects Agency for Health (ARPA-H) on September 15, 2023. The contract, set aside for total small business concerns, supports the development of intraoperative contrast agents to advance medical imaging capabilities in surgical settings. The work is being performed in Columbia, Maryland, with an ultimate completion date of December 19, 2025, under a firm fixed-price definitive contract structure.
This Phase II award represents a continuation of ARPA-H's SBIR program objectives to stimulate technological innovation and strengthen small business participation in federal research initiatives, with emphasis on translating proof-of-concept technologies toward commercial deployment. Optosurgical's track record demonstrates significant experience in this domain, evidenced by prior federal funding from NIH institutes focused on surgical imaging technologies, including multimodal laparoscopic systems and fluorescence-guided surgical applications. The contract advances ARPA-H's mission to develop transformative health technologies that address critical surgical needs through enhanced visualization and real-time guidance during operative procedures.
Quick answers
Who was awarded contract 75N91023C00053?
75N91023C00053 was awarded to Optosurgical, LLC by National Institutes of Health (Department of Health and Human Services) on September 15, 2023.
How much is contract 75N91023C00053 worth?
The government has obligated $3,500,000 on 75N91023C00053.
Was contract 75N91023C00053 competed?
The extent of competition for 75N91023C00053 was full and open competition after exclusion of sources. The government received 2 offers. It was set aside: Total Small Business.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award